Status:

RECRUITING

Clinical Validation of the Blood Pressure Measuring Device Withings BPM Pro 2 (WIHYP-GP)

Lead Sponsor:

Withings

Conditions:

Hypertension

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The aim of the study is to assess the accuracy of the automatic oscillometric BP measuring device at the brachial level, the WITHINGS BPM Pro 2, in the general population

Eligibility Criteria

Inclusion

  • Patient older than 18 years;
  • Patient who signed the informed consent form;
  • Patient followed-up at site (in-patient or out-patient);
  • Patient with arm circumference between 22 cm and 42 cm.

Exclusion

  • Patient unable to give a consent or understand properly protocol information;
  • Patient suffering from arrhythmia;
  • Patient with poor quality of Korotkov sounds;
  • Patient for whom K5 sounds are absent;
  • Patient wearing an implantable electric medical device (pacemaker,…);
  • Patient with both upper arms suffering from open wound and/or damaged skin.

Key Trial Info

Start Date :

April 28 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 30 2025

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT06957847

Start Date

April 28 2025

End Date

September 30 2025

Last Update

May 9 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

N2

Yerevan, Armenia, 0002

Clinical Validation of the Blood Pressure Measuring Device Withings BPM Pro 2 (WIHYP-GP) | DecenTrialz